rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1988-7-7
|
pubmed:abstractText |
Alcuronium 10 mg was administered to maintain muscle relaxation in two patients before recovery from suxamethonium neuromuscular blockade to facilitate tracheal intubation. This sequence resulted in a markedly prolonged block which could not be antagonised adequately by neostigmine 0.05 mg/kg; initial antagonism was followed rapidly by prolonged recurarisation. Estimation of plasma cholinesterase activity revealed that the two patients were homozygous for the atypical and silent genes. respectively.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0003-2409
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
310-1
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3377154-Adult,
pubmed-meshheading:3377154-Alcuronium,
pubmed-meshheading:3377154-Cholinesterases,
pubmed-meshheading:3377154-Female,
pubmed-meshheading:3377154-Humans,
pubmed-meshheading:3377154-Middle Aged,
pubmed-meshheading:3377154-Neostigmine,
pubmed-meshheading:3377154-Postoperative Complications,
pubmed-meshheading:3377154-Pregnancy,
pubmed-meshheading:3377154-Puerperal Disorders,
pubmed-meshheading:3377154-Succinylcholine,
pubmed-meshheading:3377154-Time Factors,
pubmed-meshheading:3377154-Toxiferine
|
pubmed:year |
1988
|
pubmed:articleTitle |
Recurarisation following a suxamethonium-alcuronium sequence in patients with atypical cholinesterase.
|
pubmed:affiliation |
Department of Anesthesiology, American University of Beirut, Lebanon.
|
pubmed:publicationType |
Journal Article,
Case Reports
|